Etuvetidigene Autotemcel: Side Effects, Uses & Monitoring
WASKYRA® is indicated for the treatment of pediatric patients aged 6 months and older and adults with Wiskott-Aldrich Syndrome (WAS) who have a mutation in the WAS gene and for whom hematopoietic stem cell transplantatio
- Data source
- FDA labeling via NIH DailyMed (label 106880df…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
WASKYRA® is indicated for the treatment of pediatric patients aged 6 months and older and adults with Wiskott-Aldrich Syndrome (WAS) who have a mutation in the WAS gene and for whom hematopoietic stem cell transplantation (HSCT) is appropriate and no suitable human leukocyte antigen (HLA)-matched related stem cell donor is available.
Conditions associated with Etuvetidigene Autotemcel in labeling
Frequently Asked Questions
What is Etuvetidigene Autotemcel used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Etuvetidigene Autotemcel?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Etuvetidigene Autotemcel require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Etuvetidigene Autotemcel.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.